Reappraisal of a 2-Cm Cut-off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study.

Published on May 1, 2021in Annals of Surgery10.13
· DOI :10.1097/SLA.0000000000003508
Laura Maggino14
Estimated H-index: 14
(University of Verona),
Andrea Schmidt1
Estimated H-index: 1
+ 10 AuthorsSébastien Gaujoux42
Estimated H-index: 42
: MINI: The characteristics of cystic pancreatic neuroendocrine neoplasms (cPanNENs) are largely unknown, and their clinical management remains unclear; specifically, an observational strategy for asymptomatic cPanNENs ≤2 cm has been proposed by recent guidelines, but evidence is scarce and limited to single institutional series. In this international cohort study of 263 resected cPanNENs from 16 institutions worldwide, a preoperative size >2 cm was independently associated with aggressive behavior both in the whole cohort and in the subset of asymptomatic patients; notably, only 1 of 61 asymptomatic cPanNENs ≤2 cm was aggressive. Based on these results, a watch-and-wait policy for sporadic asymptomatic cPanNENs ≤2 cm seems justified and safe. OBJECTIVE: The aim of this study was to characterize an international cohort of resected cystic pancreatic neuroendocrine neoplasms (cPanNENs) and identify preoperative predictors of aggressive behavior. BACKGROUND: The characteristics of cPanNENs are unknown and their clinical management remains unclear. An observational strategy for asymptomatic cPanNENs ≤2 cm has been proposed by recent guidelines, but evidence is scarce and limited to single-institutional series. METHODS: Resected cPanNENs (1995-2017) from 16 institutions worldwide were included. Solid lesions (>50% solid component), functional tumors, and MEN-1 patients were excluded. Aggressiveness was defined as lymph node (LN) involvement, G3 grading, distant metastases, and/or recurrence. RESULTS: Overall, 263 resected cPanNENs were included, among which 177 (63.5%) were >2 cm preoperatively. A preoperative diagnosis of cPanNEN was established in 162 cases (61.6%) and was more frequent when patients underwent endoscopic ultrasound [EUS, odds ratio (OR) 2.69, 95% confidence interval (CI) 1.52-4.77] and somatostatin-receptor imaging (OR 3.681, 95% CI 1.809-7.490), and for those managed in specialized institutions (OR 3.12, 95% CI 1.57-6.21). Forty-one cPanNENs (15.6%) were considered aggressive. In the whole cohort, LN involvement on imaging, age >65 years, preoperative size >2 cm, and pancreatic duct dilation were independently associated with aggressive behavior. In asymptomatic patients, older age and a preoperative size >2 cm remained independently associated with aggressiveness. Only 1 of 61 asymptomatic cPanNENs ≤2 cm displayed an aggressive behavior. CONCLUSIONS: The diagnostic accuracy of cPanNENs is increased by the use of EUS and somatostatin-receptor imaging and is higher in specialized institutions. Preoperative size >2 cm is independently associated with aggressive behavior. Consequently, a watch-and-wait policy for sporadic asymptomatic cPanNENs ≤2 cm seems justified and safe for most patients.
📖 Papers frequently viewed together
10 Citations
211 Citations
7 Authors (Jae Gu Jung, ..., Jong Chul Rhee)
25 Citations
#1Stefano PartelliH-Index: 43
#2Francesca MuffattiH-Index: 14
Last. Massimo FalconiH-Index: 105
view all 10 authors...
Abstract Background Concerns exist about a conservative management of well-differentiated nonfunctioning small pancreatic neuroendocrine tumors (NF-PanNET) in young patients and when preoperative Ki67 proliferative index is ≥3%. Aim To evaluate an association between age, tumor size and grading in patients with sporadic NF-PanNET who underwent curative resection. Methods Patients who underwent surgery for sporadic NF-PanNET (excluding G3) were retrospectively analyzed. Linear regression analysis...
5 CitationsSource
#1Stefano PartelliH-Index: 43
#2Domenico TamburrinoH-Index: 16
Last. Giuseppe Fusai (Royal Free Hospital)H-Index: 30
view all 9 authors...
OBJECTIVES: Pancreaticoduodenectomy (PD) is associated with a high risk of postoperative complications and mortality. The aim of this study was to compare postoperative morbidity after PD in patients undergoing resections for pancreatic neuroendocrine neoplasms (PanNENs) with patients undergoing the same resection for pancreatic ductal adenocarcinoma (PDAC). METHODS: Data of 566 patients from 3 European tertiary referral centers between 1998 and 2014 were considered. RESULTS: Overall, 566 patien...
7 CitationsSource
1 CitationsSource
#1Rosalie A. Carr (IU: Indiana University)H-Index: 5
#2Panagiotis Bletsis (IU: Indiana University)H-Index: 1
Last. Eugene P. Ceppa (IU: Indiana University)H-Index: 23
view all 8 authors...
Abstract Background Pancreatic neuroendocrine tumors (PNETs) are predominantly solid lesions with malignant potential. Cystic PNETs are a small subset in which data are scarce. The aim of this study was to compare clinical and biologic differences between cystic and solid PNETs. Methods Patients with PNETs undergoing pancreatectomy between 1988 and 2016 at a high-volume center were reviewed retrospectively. Demographic, clinical, and histopathologic data were collected and analyzed. Results 347 ...
4 CitationsSource
#1Ville Sallinen (HYKS: Helsinki University Central Hospital)H-Index: 20
Last. Sébastien Gaujoux (University of Paris)H-Index: 42
view all 23 authors...
Background: Malignant potential of small (<= 20 mm) nonfunctional pancreatic neuroendocrine tumors (sNF-PNET) is difficult to predict and management remain controversial. The aim of this study w ...
45 CitationsSource
#1René VonlanthenH-Index: 9
#2Peter Lodge (St James's University Hospital)H-Index: 10
Last. Pierre-Alain ClavienH-Index: 121
view all 28 authors...
Objectives:To critically assess centralization policies for highly specialized surgeries in Europe and North America and propose recommendations.Background/Methods:Most countries are increasingly forced to maintain quality medicine at a reasonable cost. An all-inclusive perspective, including health
59 CitationsSource
#1Cansu Guney GencH-Index: 4
#2Massimo Falconi (UniSR: Vita-Salute San Raffaele University)H-Index: 105
Last. E.J.M. Nieveen van DijkumH-Index: 10
view all 9 authors...
Background Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival after curative resection of panNET.
36 CitationsSource
#1Marco Del ChiaroH-Index: 31
#2Marc G. Besselink (UniSR: Vita-Salute San Raffaele University)H-Index: 1
Last. L. WustenH-Index: 1
view all 89 authors...
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association, European Digestive Surgery, and the European Society of Gastrointestinal Endoscopy. It replaces the 2013 European consensus statement guidelines on PCN. European and non-European experts perf...
312 CitationsSource
#1Grace H. Elta (UM: University of Michigan)H-Index: 48
#2Brintha K. Enestvedt (OHSU: Oregon Health & Science University)H-Index: 18
Last. Anne Marie Lennon (Johns Hopkins University)H-Index: 43
view all 4 authors...
Pancreatic cysts are very common with the majority incidentally identified. There are several types of pancreatic cysts; some types can contain cancer or have malignant potential, whereas others are benign. However, even the types of cysts with malignant potential rarely progress to cancer. At the p
143 CitationsSource
#1Luca Landoni (University of Verona)H-Index: 19
#2Giovanni Marchegiani (University of Verona)H-Index: 29
Last. Claudio BassiH-Index: 110
view all 26 authors...
OBJECTIVE: The objective of the present analysis is 2-fold: first, to define the evolution of time trends on the surgical approach to pancreatic neuroendocrine neoplasms (Pan-NENs); second, to perform a complete analysis of the predictors of oncologic outcome. BACKGROUND: Reflecting their rarity and heterogeneity, Pan-NENs represent a clinical dilemma. In particular, there is a scarcity of data regarding their long-term follow-up after surgical resection. METHODS: From the Institutional Pan-NEN ...
23 CitationsSource
Cited By2
#1Masayuki Tanaka (Keio: Keio University)H-Index: 8
#2Max Heckler (Heidelberg University)H-Index: 6
Last. Thilo Hackert (Heidelberg University)H-Index: 57
view all 9 authors...
The optimal surgical strategy for pancreatic neuroendocrine tumors (PNETs) is unknown. However, current guidelines recommend a watch-and-wait strategy for small nonfunctional PNETs (NF-PNETs). The aim of this study is to investigate the risk stratification and prognostic significance of lymph node metastasis (LNM) of PNETs to guide decision-making for lymphadenectomy. The MEDLINE and Web of Science databases were systematically searched for studies reporting either risk factors of LNM in resecte...
3 CitationsSource
#1Charlotte M. Heidsma (UvA: University of Amsterdam)H-Index: 2
#1Charlotte M Heidsma (OSU: Ohio State University)
Last. Timothy M. Pawlik (The Ohio State University Wexner Medical Center)H-Index: 118
view all 12 authors...
Background: We sought to define the diagnostic yield and concordance rates between endoscopic ultrasound (EUS)-fine-needle aspiration (FNA) and surgical pathology specimen following resection of pancreatic neuroendocrine tumors (pNET) less than 2 cm. Methods: Patients with a pNET less than 2 cm who underwent EUS-FNA were identified using a multi-institutional international database. Tumor differentiation, and Ki-67 index, as determined through EUS-FNA were examined and concordance rates between ...
1 CitationsSource